Focus: Juvise Pharmaceuticals is a small-molecule focused pharmaceutical company headquartered in Paris with specialization in neurology therapeutics. Limited public data suggests an early-to-mid stage operation with a focused pipeline.
Profile data last refreshed 17h ago · AI intelligence enriched 1mo ago
Stable — net +1 jobs in 30d
2 added, 1 removed. Backfill posture.
Juvise represents a speculative early-stage opportunity best suited to risk-tolerant candidates seeking foundational roles in a neurology-focused biotech, pending visibility into pipeline depth and funding stability.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Juvise Pharmaceuticals
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Juvise Pharmaceuticals's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Based on last 4 crawl cycles
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo